Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Finzel

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
Annals of the Rheumatic Diseases|June 22, 2016
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugsCamille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, et al.
The Journal of Rheumatology|February 3, 2017
The OMERACT Ultrasound Group: A Report from the OMERACT 2016 Meeting and PerspectivesLene Terslev, Annamaria Iagnocco, George A W Bruyn, et al.
The Lancet. Rheumatology|February 1, 2024
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Tascilar, Melanie Hagen, Arnd Kleyer, et al.
The Journal of Rheumatology|September 3, 2011
The OMERACT ultrasound task force--status and perspectivesEsperanza Naredo, Richard J Wakefield, Annamaria Iagnocco, et al.
Journal of Clinical Medicine|June 10, 2023
Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO TrialMarlene Stephan, Koray Tascilar, Melek Yalcin-Mutlu, et al.
The Journal of Rheumatology|November 19, 2013
Responsiveness in rheumatoid arthritis. a report from the OMERACT 11 ultrasound workshopAnnamaria Iagnocco, Esperanza Naredo, Richard Wakefield, et al.
Rheumatology (Oxford, England)|December 1, 2021
Development of a new ultrasound scoring system to evaluate glandular inflammation in Sjögren's syndrome: an OMERACT reliability exerciseAlojzija Hočevar, George A Bruyn, Lene Terslev, et al.
Annals of the Rheumatic Diseases|November 5, 2025
EULAR 2025 classification criteria for haemochromatosis arthropathyPatrick Dw Kiely, Stephanie Finzel, Bayram Farisogullari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2023
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic SclerosisRobert Spiera, Masataka Kuwana, Dinesh Khanna, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
Annals of the Rheumatic Diseases|June 22, 2016
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugsCamille P Figueiredo, Holger Bang, Jayme Fogagnolo Cobra, et al.
The Journal of Rheumatology|February 3, 2017
The OMERACT Ultrasound Group: A Report from the OMERACT 2016 Meeting and PerspectivesLene Terslev, Annamaria Iagnocco, George A W Bruyn, et al.
The Lancet. Rheumatology|February 1, 2024
Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialKoray Tascilar, Melanie Hagen, Arnd Kleyer, et al.
The Journal of Rheumatology|September 3, 2011
The OMERACT ultrasound task force--status and perspectivesEsperanza Naredo, Richard J Wakefield, Annamaria Iagnocco, et al.
Journal of Clinical Medicine|June 10, 2023
Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO TrialMarlene Stephan, Koray Tascilar, Melek Yalcin-Mutlu, et al.
The Journal of Rheumatology|November 19, 2013
Responsiveness in rheumatoid arthritis. a report from the OMERACT 11 ultrasound workshopAnnamaria Iagnocco, Esperanza Naredo, Richard Wakefield, et al.
Rheumatology (Oxford, England)|December 1, 2021
Development of a new ultrasound scoring system to evaluate glandular inflammation in Sjögren's syndrome: an OMERACT reliability exerciseAlojzija Hočevar, George A Bruyn, Lene Terslev, et al.
Annals of the Rheumatic Diseases|November 5, 2025
EULAR 2025 classification criteria for haemochromatosis arthropathyPatrick Dw Kiely, Stephanie Finzel, Bayram Farisogullari, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2023
Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic SclerosisRobert Spiera, Masataka Kuwana, Dinesh Khanna, et al.
Pageof 9